Evidence map›Paper›PMID 42884120›Full record

ArticleInternational journal of molecular sciences2026

Evidence-Tiered Venomics of the BotG50 Toxic Fraction from

Rym ElFessi, Rahma Ben Abderrazek, Urvashi Khurana, Thierry Pourcher, Riadh Kharrat, Saïd Bendahhou, Riadh Marrouchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rym ElFessiLaboratory of Venoms and Therapeutic Biomolecules, Institut Pasteur de Tunis, Université de Tunis El Manar, 13 Place Pasteur, BP74, Tunis 1002, Tunisia.
Rahma Ben AbderrazekLaboratory of Biomolecules, Venoms and Theranostic Applications (LBVAT), Institut Pasteur de Tunis, Université de Tunis El Manar, 13 Place Pasteur, BP74, Tunis 1002, Tunisia.
Urvashi KhuranaLaboratoire de PhysioMédecine Moléculaire (LP2M), UMR 7370, CNRS, Université Côte d'Azur, 06107 Nice, France.
Thierry PourcherLaboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des Sciences du Vivant Frédéric Joliot, Commissariat à l'Énergie Atomique et aux Énergies Alterna-tives (CEA), Université Côte d'Azur, 06107 Nice, France.ORCID 0000-0003-2839-4622
Riadh KharratLaboratory of Venoms and Therapeutic Biomolecules, Institut Pasteur de Tunis, Université de Tunis El Manar, 13 Place Pasteur, BP74, Tunis 1002, Tunisia.
Saïd BendahhouLaboratoire de PhysioMédecine Moléculaire (LP2M), UMR 7370, CNRS, Université Côte d'Azur, 06107 Nice, France.
Riadh MarrouchiLaboratory of Venoms and Therapeutic Biomolecules, Institut Pasteur de Tunis, Université de Tunis El Manar, 13 Place Pasteur, BP74, Tunis 1002, Tunisia.ORCID 0000-0003-2311-576X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scorpion venoms represent complex pharmacological arsenals whose complete molecular inventory remains incompletely defined, particularly for North African buthid species of high medical relevance.

Indexed as

NeurotoxinsScorpionsScorpion VenomsAmino Acid SequenceAnimalsProtein Processing, Post-TranslationalProteomeProteomicsTandem Mass SpectrometryNeurotoxinsProteomeScorpion VenomsCasanovo de novo sequencingion-channel toxinsnanoLC-MS/MSpost-translational modificationsscorpion venomics

Identifiers

PMID42884120
PMCPMC13664939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.